Trademark applications and grants for Satsuma Pharmaceuticals, Inc.. Satsuma Pharmaceuticals, Inc. has 1 trademark applications. The latest application filed is for "ATZUMI"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | Suite 221 400 Oyster Point Boulevard South San Francisco, CALIFORNIA UNITED STATES 94080 |
Patent Application | Date |
---|---|
Compositions, Devices, and Methods for Treating or Preventing Headaches 20200345730 - 16/933560 KOLLINS; John ;   et al. | 2020-11-05 |
INTRANASAL DHE FOR THE TREATMENT OF HEADACHE 20200179379 - 16/791431 HARUTA; Shunji ;   et al. | 2020-06-11 |
Compositions, Devices, and Methods for Treating or Preventing Headaches 20200179378 - 16/710538 KOLLINS; John ;   et al. | 2020-06-11 |
Intranasal DHE for the Treatment of Headache 20190275036 - 16/414350 Haruta; Shunji ;   et al. | 2019-09-12 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"ATZUMI" 97365929 |
ATZUMI 2022-04-15 |
SEC | 0001692830 | Satsuma Pharmaceuticals, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.